Upcoming Industry Events & Training Opportunities

Transcription

1 Certification Commission for Drug & Alcohol Program Professionals Commission Launches New Member Features Expert Help Forum, Desk Reference and On Board Button As part of CCDAPP s commitment to enhancing the benefits of being a Certified Drug and Alcohol Program Professional, the commission recently launched three new features to include an online forum, study guide and an innovative way to demonstrate your credential. No Man is an Island Certification-holders have extensive industry knowledge and many years of experience, yet it s unlikely that any one individual would be willing to state that they are adept at every aspect of our industry. However, collectively our CCDAPP certification holders offer hundreds of years of practical application and expertise in all facets of the drug and alcohol testing industry. The CCDAPP Expert Help Forum is designed to open dialogue between members enabling us to share our strengths with one another as well as combat the copious amount of inaccurate information found on the Internet. Please visit to register for the forum. You will receive a confirmation once your account is activated. At Your Fingertips Regulations, reference links and more have been compiled and organized in the CCDAPP Study Guide and Desk Reference Manual which is now available on our website as a free download for all CCDAPP certification holders and approved applicants preparing for their exam. Please CCDAPP s Executive Director, Jennifer, to receive your password. Exec.dir@ccdapp.org The following individuals have recently earned initial certification or renewed certification! Newly Certified: Roxanne Lepre, CSAPA Renewed Certification: Valerie Fernandez, CSAPA Shelia Guzman, CSAPA Cleve Miller, CSAPA Eva Ojeda, CSAPA Linda Richardson, CSAPA Continued on Page 3 Upcoming Industry Events & Training Opportunities 12 th Annual FTA Drug and Alcohol Program National Conference April 18-20, 2017, New Orleans, LA DATIA Annual Conference May 16-18, 2017, Orlando, FL USDOT s Transportation Safety Institute Substance Abuse Management and Program Compliance; Classes available in Kentucky, South Dakota, California and Maryland, May through August. Visit the TSI website for further detail: 67&tab_id=

2 OSHA Publishes New Regulations B la nket po st -accid ent test in g no w p ro hib it ed Have you or your clients faced any challenges as a result of this new law? Join the discussion on our expert-help forum: In May 2016, the Occupational Safety and Health Administration (OSHA) published new regulations regarding the tracking of workplace injuries (81 FR 29624, 5/12/16). The preamble to the regulation notified employers that blanket post-accident drug and alcohol testing would no longer be permitted. This means that employer policies can no longer state that post-accident drug testing will occur any time there is an injury requiring medical treatment away from the scene of accident or a particular dollar amount of damage associated with the accident. The potential civil penalty (fine) for violations is $12,471. The implementation date of the regulation was delayed twice as a court challenge progressed. On November 28, 2016 the Federal judge declined to allow an injunction, and the regulation was implemented on December 1, Click here for the guidance published by OSHA: recordkeeping_ html Benefits of CCDAPP Corporate Sponsorship Our commission is a non-profit organization striving to enhance and promote the level of professional knowledge of individuals providing drug and alcohol testing services. Corporate leaders who recognize the importance of raising the bar within our industry can demonstrate their commitment through sponsorship opportunities. Some of the benefits of becoming a CCDAPP Corporate Sponsor include: placement of your corporate logo on the CCDAPP website and in our quarterly newsletters as well as the opportunity to author spotlight articles for publication in the newsletters. For further information regarding sponsorship, please CCDAPP s Executive Director, Jennifer Peacock: exec.dir@ccdapp.org 2 Oh the joys of prepping for an audit! Pictured: Diane Northrop Dallas Area Rapid Transit

3 Continued from page 1. Button-up CCDAPP has developed a new means of identifying that a certified individual is on board within your organization. Logos of varying sizes can be added to websites, signatures and printed material to demonstrate an employer s commitment to hiring and retaining individuals holding the highest level of certification available within our industry. To obtain the new logo buttons for CSAPA and CDAPA certification holders, visit: DOT Published Notice of Proposed Rule Making (NPRM) On January 23, 2017 the DOT published an NPRM that would add four opioids to the drug-testing panel and update several testing program provisions. While the addition of hydrocodone, hydromorphone, oxycodone and oxymorphone to the testing panel has been anticipated for quite some time, but a few of the other program provisions contained within the NPRM may not have been on our radar: Removal of the requirement for employers and C/TPAs to submit blind specimens to the labs Requirement for collectors, MROs, STTs, BATs and SAPs to subscribe to the DOT s list-serve Removal of the list of approved SAP certification organizations from Part 40 (list will be maintained on DOT s website) Addressing what a collector must do when a specimen is questionable and the donor is unable to provide a second specimen Prohibiting service agents from using the DOT logo and branding to represent endorsement from the agency View the full NPRM here: 3

4 A new specimen for drug testing? Don t hold your breath! In January of 2015, The Journal of Chromatography B published the findings of researchers from the Department of Laboratory Medicine at the Karolinska Institute, Sweden, who had developed and validated drug testing using exhaled breath. The principle behind the breath test is that aerosol particles become contaminated with the drugs from the fluid lining the airways as they are exhaled. These aerosol particles are then collected onto a filter by a sampling device. The filter containing the particles is then used for testing in the laboratory by mass spectrometry. The researchers tested and validated this new method in routine drug testing. They used a total of 1096 samples over a period of 12 months for detection of amphetamine, methamphetamine, 6- acetylmorphine, morphine, benzoylecgonine, diazepam, oxazepam, and tetrahydrocannabinol. The study describes the fully validated method of drug testing and further applies it to routine measurement on samples that were sent for drug testing. The study also reports for the first time on the levels of drug present in 39 positive samples derived from breath testing. The authors report that this method of breath testing has potential for a wide variety of uses, ranging from clinical applications where urine sampling is more difficult, and compliance testing during drug addiction treatment, criminal justice applications, workplace drug testing, and accident investigations. The researchers are also planning to develop a test for therapeutic drug use by exhaled breath; testing for this is currently underway. Those interested in learning more may purchase and download the complete study: What are your thoughts on the potential use of breath specimens for drug testing? Start a discussion on our expert-help forum: 4

5 CCDAPP Newsletter Q1/2017 Editor and Contributor: Diana Byrnes, CSAPA Editorial Review: Jana Wolfgang, CSAPA; Jennifer Peacock, Exec. Director Please direct comment to: CCDAPP Officers: Robi Bolton, CSAPA, President Diana Byrnes, CSAPA, Vice-President Jana Wolfgang, CSAPA, Secretary Diane Northrop, CSAPA, Treasurer CCDAPP Commissioners: Mary Brown-Ybos, CSAPA Cindy Decker, CSAPA Dr. Martin Duke, MRO Regina Doural, CSAPA Dennis Kerns, CSAPA Venus Mills, CSAPA Dr. Richard Plut Tom Pool, CSAPA Brandie Reid, CSAPA Jeff Sims, CSAPA Helen White, CSAPA CCDAPP is grateful for the sponsorship our commission receives. If your organization is interested in learning more about the benefits of becoming a CCDAPP sponsor, please Jennifer Peacock: exec.dir@ccdapp.org